Atrial natriuretic hormone decreases endocrine response to a combined dexamethasone-corticotropin-releasing hormone test

Biological Psychiatry

Volumn 43, Issue 5, 1998, Pages 371-375

  Ströhle, Andreas ^a   Kellner, Michael ^a   Holsboer, Florian ^a   Wiedemann, Klaus ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Atrial natriuretic hormone; Corticotropin; Corticotropin releasing hormone; Cortisol; Dexamethasone corticotropin releasing hormone test; Hypothalamic pituitary adrenocortical system

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; HYDROCORTISONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN RELEASE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ADRENOCORTICOTROPIC HORMONE; ADULT; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; CORTICOTROPIN-RELEASING HORMONE; DEPRESSIVE DISORDER; DEXAMETHASONE; ENDOCRINE GLANDS; GLUCOCORTICOIDS; HEART RATE; HEMODYNAMIC PROCESSES; HUMANS; HYDROCORTISONE; MALE;

EID: 0032030538     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(97)00200-X     Document Type: Article

References (33)

1. Antoni FA, Hunter EFM, Lowry PJ, Noble JM, Seckl JR. Atriopeptin An endogenous corticotropin-release inhibiting hormone . Endocrinology. 130:1992;1753-1755.
2. Carr BR, Mason JI. The effects of alpha-human atrial natriuretic polypeptide on steroidgenesis by fetal zone cells of the human fetal adrenal gland. Am J Obstet Gynecol. 159:1988;1361-1365.
3. Crandall ME, Gregg CM. In vitro evidence for an inhibitory effect of atrial natriuretic peptide on vasopressin release. Neuroendocrinology. 44:1986;439-445.
4. Dayanithi G, Antoni FA. Atriopeptins are potent inhibitors of ACTH secretion by rat anterior pituitary cells in vitro Involvement of the atrial natriuretic factor receptor domain of membrane-bound guanylyl cyclase . J Endocrinol. 125:1990;39-44.
5. de Bold AJ, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats. Life Sci. 28:1981;89-94.
6. Fink G, Dow RC, Casley D, Johnston CI, Lim AT, Copolov DL, et al. Atrial natriuretic peptide is a physiological inhibitor of ACTH release Evidence from immunoneutralization in vivo . J Endocrinol. 131:1991;R9-R12.
7. Fink G, Dow RC, Casley D, Johnston CI, Bennie J, Carroll S, et al. Atrial natriuretic peptide is involved in the ACTH response to stress and glucocorticoid negative feedback in the rat. J Endocrinol. 135:1992;37-43.
8. Gardner DG, Hane S, Trachewsky D, Schenk D, Baxter JD. Atrial natriuretic peptide RNA is regulated by glucocorticoids in vivo. Biochem Biophys Res Commun. 139:1986;1047-1054.
9. Gutkowska J, Nemer M. Structure, expression, and function of atrial natriuretic factor in extraatrial tissues. Endocr Rev. 10:1989;519-536.
10. Holsboer F. Neuroendocrinology of mood disorders. Bloom F, Kupfer DJ. Psychopharmacology The Fourth Generation of Progress . 1995;957-969 Raven Press, New York.
11. Holsboer F, Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr Rev. 17:1996;187-205.
12. Holsboer F, von Bardeleben U, Wiedemann K, Müller OA, Stalla GK. Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression - implications for pathophysiology of DST nonsuppression. Biol Psychiatry. 22:1987;228-234.
13. Ibanez-Santoz J, Tsagarakis S, Rees LH, Besser GM, Grossman A. Atrial natriuretic peptides inhibit the release of corticotrophin-releasing factor-41 from rat hypothalamus. J Endocrinol. 126:1990;223-238.
14. Iitake K, Share L, Crofton JT, Brooks DP, Ouchi Y, Blaine EH. Central atrial natriuretic factor reduced vasopressin secretion in the rat. Endocrinology. 119:1986;438-440.
15. Kellner M, Wiedemann K, Holsboer F. ANF inhibits the CRH-stimulated secretion of ACTH and cortisol in man. Life Sci. 50:1992;1835-1842.
16. Kellner M, Herzog I, Holsboer F, Wiedemann K. Circadian changes in the sensitivity of the corticotropin-releasing hormone-stimulated HPA system after arginine vasopressin and atrial natriuretic hormone in human male controls. Psychoneuroendocrinology. 20:1995;515-524.
17. King MS, Baertschi AJ. Physiological concentrations of atrial natriuretic factors with intact N-terminal sequences inhibit corticotrophin-releasing factor-stimulated adrenocorticotropin from cultured anterior pituitary cells. Endocrinology. 124:1989;286-292.
18. Kovacs KJ, Antoni FA. Atriopeptin inhibits stimulated secretion of adrenocorticotropin in rats Evidence for a pituitary site of action . Endocrinology. 127:1990;3003-3008.
19. Lachance D, Garcia R, Gutowska J, Cantin M, Thibault G. Mechanisms of release of atrial natriuretic factor I. Effects of several agonists and steroids on its release by atrial myocytes . Biochem Biophys Res Commun. 135:1986;1090-1098.
20. Matsubara H, Hirata Y, Yoshimi H, Takata S, Takagy Y, Iida T, et al. Effects of steroid and thyroid hormones on synthesis of atrial natriuretic peptide by cultured atrial myocytes of rat. Biochem Biophys Res Commun. 145:1987;336-343.
21. Nawata H, Ohashi M, Haji M, Takayanagi R, Higuchi K, Fujio N, et al. Atrial and brain natriuretic peptide in adrenal steroidogenesis. J Steroid Biochem Mol Biol. 40:1991;367-379.
22. Obana K, Naruse M, Inagami T. Atrial natriuretic factor inhibits vasopressin secretion from rat posterior pituitary. Biochem Biophys Res Commun. 132:1985;1088-1094.
23. Samson WK. Atrial natriuretic factor inhibits dehydration- and hemorrhage-induced vasopressin release. Neuroendocrinology. 40:1985;277-279.
24. Samson WK, Aguila MC, Martinovic J, Antunes-Rodrigues J, Norris M. Hypothalamic action of atrial natriuretic factor to inhibit vasopressin secretion. Peptides. 8:1987;449-454.
25. Shilo L, Pomeranz A, Rathaus M, Weiss E, Bernheim J, Shenkman L. Atrial natriuretic peptide administration to normal and salt depleted rats - Effects on digoxin-like immunoreactive factor, aldosterone, ACTH, and renal function. Life Sci. 42:1988;1855-1859.
26. Standaert DG, Cechetto DF, Needleman P, Saper CB. Inhibition of the firing of vasopressin neurons by atriopeptin. Nature. 329:1987;151-153.
27. Takahashi H, Okabayashi H, Suga K, Matsuzawa M, Ikegaki I, Yoshimura M, et al. Inhibitory roles of the hypothalamic atrial natriuretic polypeptide on the vasopressin release in the sodium-loaded rats. Biochem Biophys Res Commun. 139:1986;1285-1291.
28. Takao T, Hashimoto K, Ota Z. Effect of atrial natriuretic peptide on acethylcholine-induced release of corticotropin-releasing factor from rat hypothalamus in vitro. Life Sci. 42:1988;1199-1203.
29. von Bardeleben U, Holsboer F. Cortisol response to a combined dexamethasone-human corticotropin-releasing hormone challenge in patients with depression. J Neuroendocrinol. 1:1989;485-488.
30. von Bardeleben U, Holsboer F. Effect of age on the cortisol response to human corticotropin-releasing hormone in depressed patients with dexamethasone. Biol Psychiatry. 29:1991;1042-1050.
31. von Bardeleben U, Holsboer F, Stalla GK, Müller OA. Combined administration of human corticotropin-releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects. Life Sci. 37:1985;1613-1618.
32. Wiedemann K, Holsboer F. Plasma dexamethasone kinetics during the DST after oral and intravenous administration of the test drug. Biol Psychiatry. 22:1987;1340-1348.
33. Weidmann P, Matter DR, Matter EE, Gnädinger MP, Uehlinger DE, Shaw S. Glucocorticoid and mineralocorticoid stimulation of atrial natriuretic peptide release in man. J Clin Endocrinol Metab. 66:1988;1233-1239.